The Patient Health Questionnaire-9 is not a diagnostic shortcut.
It is a validated severity measure that translates abstract emotional distress into a structured numerical baseline.
When administered correctly, it catches subtle symptom shifts that a standard conversational intake often misses.
But dropping a stark nine-question grid in front of a new patient without context can damage trust before the session even begins.
Here is how to implement, score, and introduce the PHQ-9 effectively in your clinical workflow.
What is the PHQ-9 and what does it measure?
The PHQ-9 was developed to bring the strict diagnostic criteria of the DSM-5 into a fast, patient-reported format. Instead of relying on a provider's subjective impression of a patient's mood, the tool asks the patient to self-report their symptom frequency over the past two weeks. This timeframe is critical because a Major Depressive Episode requires symptoms to be present consistently for at least 14 days.
The questionnaire consists of exactly nine questions. Each question maps directly to one of the nine core criteria for Major Depressive Disorder, isolating specific behavioral and physical changes.
- Anhedonia: The first question measures a loss of interest or pleasure in doing things. Clinically, this captures the suppression of the brain's reward system, where hobbies, socializing, or daily routines no longer provide a normal dopamine response.
- Depressed mood: Question two directly assesses feeling down, depressed, or hopeless. This is the subjective emotional core of depression, reflecting the patient's internal narrative and overall outlook on their current situation.
- Sleep disturbance: Question three looks for insomnia or hypersomnia. It specifically asks about trouble falling asleep, staying asleep, or sleeping too much, as depressive episodes frequently disrupt the body's natural circadian rhythms.
- Fatigue: Question four measures physical energy levels. Feeling tired or having little energy is often the most stubborn symptom to resolve during treatment, heavily impacting a patient's ability to maintain employment or household duties.
- Appetite changes: Question five tracks significant metabolic and behavioral eating shifts. Patients report either poor appetite leading to unintended weight loss, or overeating as a self-soothing mechanism to cope with emotional numbness.
- Guilt and worthlessness: Question six targets severe cognitive distortions. It asks if the patient feels bad about themselves, feels like a failure, or believes they have let their family down, which often points to deeply internalized shame.
- Concentration problems: Question seven evaluates cognitive impairment. It measures difficulty focusing on routine tasks like reading the newspaper or watching television, highlighting the executive dysfunction common in severe depressive episodes.
- Psychomotor changes: Question eight observes physical agitation or retardation. It asks if the patient is moving or speaking noticeably slower than usual, or conversely, if they are unusually restless and fidgety compared to their normal baseline.
- Suicidal ideation: Question nine assesses passive or active thoughts of death. It specifically asks about thoughts that the patient would be better off dead, or thoughts of hurting themselves in some way.
Expert tip: When reviewing the responses, look closely at the first two items. If a patient does not score at least a "1" on either anhedonia or depressed mood, a formal diagnosis of Major Depressive Disorder is highly unlikely, regardless of their total score on the remaining somatic items.
How is the depression screening questionnaire scored?
Scoring the PHQ-9 relies on a simple mathematical summation of the patient's self-reported frequencies. Each of the nine questions offers four Likert-style response options based on how often the symptom occurred. The patient selects how often they have been bothered by each issue over the preceding two weeks.
The response weights are fixed and escalate with frequency.
Not at all scores a 0.
Several days scores a 1.
More than half the days scores a 2.
Nearly every day scores a 3.
By adding the scores of all nine questions, you generate a total severity score ranging from 0 to 27. This total score places the patient into one of five validated severity brackets. Each bracket corresponds to a standard clinical recommendation for the provider.
| Score range | Severity level | Recommended clinical action |
|---|---|---|
| 0 - 4 | None to minimal | No specific depression treatment required; monitor if clinical suspicion remains high. |
| 5 - 9 | Mild | Watchful waiting; provide psychoeducation and repeat the assessment at the next follow-up. |
| 10 - 14 | Moderate | Consider initiating a treatment plan, which may include therapy, counseling, or active monitoring. |
| 15 - 19 | Moderately severe | Initiate active treatment with pharmacotherapy, psychotherapy, or a structured combination of both. |
| 20 - 27 | Severe | Immediate initiation of pharmacotherapy and expedited referral for specialized psychiatric care. |
A score of 10 is the widely accepted threshold for identifying clinically significant depression. At a score of 10 or higher, the sensitivity and specificity for major depression are both excellent. Patients scoring in the moderate range or higher generally require some form of active clinical intervention.
However, the total score is only part of the clinical picture. If question nine regarding suicidal ideation receives any score higher than 0, standard scoring logic stops. The severity action plan is immediately superseded by your practice's safety and crisis assessment protocols.
What are the clinical limitations of the patient health questionnaire?
The PHQ-9 is a highly reliable screening instrument, but it cannot replace human clinical judgment. Relying on the total score without conducting a follow-up clinical interview leads to diagnostic errors. The tool measures symptom presence and frequency, but it cannot determine the underlying root cause of those symptoms.
One of the most dangerous misinterpretations is assuming a high score confirms unipolar major depression. The questionnaire does not screen for a history of manic or hypomanic episodes. Prescribing an SSRI based solely on a high score to a patient who actually has undiagnosed bipolar disorder risks triggering a severe manic episode.
False-positive risks are also particularly high in primary care and specialized medical settings. Many physical conditions perfectly mimic the somatic symptoms of depression, artificially inflating the final score.
- Chronic pain: Patients with severe arthritis or fibromyalgia naturally report poor sleep, low energy, and difficulty concentrating due to their physical pain.
- Endocrine disorders: Untreated hypothyroidism directly causes profound fatigue, weight changes, and sluggish psychomotor activity.
- Acute illness: A patient recovering from a severe viral infection will score highly on fatigue and appetite loss, reflecting their immune response rather than a mood disorder.
- Normal bereavement: A patient who recently lost a spouse will likely score in the severe range, but this reflects acute grief, not necessarily a pathological depressive episode.
Clinical exceptions exist regarding patient comprehension, literacy, and cultural background. The questionnaire requires the ability to accurately estimate timeframes over a two-week period. Patients with early-stage dementia or significant cognitive impairment often struggle to recall symptom frequency accurately, requiring collateral information from a caregiver. Additionally, in many cultures, depression is primarily expressed through physical complaints rather than emotional ones, which can skew self-reporting on questions about mood and guilt.
Finally, response bias always plays a role in self-reported psychological data.
Patients fearful of stigma, mandatory hospitalization, or losing custody of children may deliberately underreport their distress.
This "faking good" behavior hides severe symptoms behind a reassuring score of 3 or 4.
Conversely, patients experiencing extreme temporary stress may catastrophize their symptoms, rating everything as Nearly every day and artificially maxing out the score.
How do you introduce the PHQ-9 sensitively during clinical intake?
Handing a patient a clipboard with questions about suicide and self-worth without preamble is a fast way to damage rapport. Patients often feel defensive when confronted with a psychological screening, especially if they came in for a purely physical complaint. The way you frame the questionnaire determines how honestly the patient will answer. You must normalize the process, explain its purpose, and clarify that it is a routine part of your care standard.
For verbal introductions during an in-person intake, focus on routine and thoroughness. Avoid framing it as a pass/fail "depression test."
Verbal introduction
- ❌ Weak: "I need you to take this depression test so I can put your score in the chart before the doctor comes in."
- ✅ Strong: "To make sure we are looking at your whole health, we ask all our patients to complete this brief nine-question survey. It gives us a helpful baseline of how your energy, sleep, and mood have been over the last two weeks."
If your practice sends paperwork ahead of time, the email invitation sets the tone before the patient even arrives. Automated messages from an EHR can sound cold, robotic, and alarming if they just drop a link to a mental health screening. A well-crafted email invitation increases completion rates and reduces pre-appointment anxiety.
Email invitation
- ❌ Weak: "Please click the link below to fill out your mandatory psychiatric intake forms before your visit."
- ✅ Strong: "Before your appointment, please complete the attached brief health questionnaire. We use this standard form with every patient to understand your current sleep, energy levels, and overall mood. Answering these questions honestly helps us tailor our conversation to exactly what you need right now."
When building digital intake forms in healthcare settings, the text immediately preceding the questions is your last chance to provide context. Keep the online form intro text short, clear, and focused on the specific timeframe.
Online form intro text
- ❌ Weak: "Fill out the PHQ-9 depression scale below. Check the box that applies to you."
- ✅ Strong: "The following 9 questions ask about how you have been feeling recently. Please read each item carefully and select the option that best describes how often you have been bothered by these issues over the past two weeks. There are no right or wrong answers."
How should you structure the questionnaire in digital intake forms?
Moving the PHQ-9 from a paper handout to a digital screen requires careful formatting to prevent survey fatigue. If you present nine separate dropdown menus or nine sprawling lists of radio buttons, the cognitive load on the patient increases dramatically. The most efficient way to build this in a tool like Google Forms or a modern EHR is to use a multiple-choice grid or matrix format. This layout keeps the frequency options visible at the top, allowing the patient to read down the list of symptoms quickly and naturally.
Follow this step-by-step configuration to build a clean, accessible grid.
- Select the question type: Add a new question block and set the input type to
Multiple choice gridorMatrix. - Draft the prompt: In the main question title field, type the standardized prompt: Over the last 2 weeks, how often have you been bothered by any of the following problems?
- Configure the columns: Enter the four standardized frequency options exactly as written in the validated tool. Set Column 1 to
Not at all, Column 2 toSeveral days, Column 3 toMore than half the days, and Column 4 toNearly every day. - Populate the rows: Enter the nine symptom descriptions into the row fields sequentially. Keep the exact phrasing of the official questionnaire to maintain clinical validity and ensure accurate scoring.
- Enforce completion: Toggle the setting for
Require a response in each row. This prevents patients from accidentally skipping a symptom, which would invalidate the total score calculation and force you to chase them down for the missing data.
Isolating question nine is a vital structural consideration in digital workflows. Because question nine deals with self-harm, burying it at the bottom of a long visual grid can cause patients to skim past it or answer reflexively. Some clinics choose to pull question nine out of the main grid entirely. They format it as a standalone multiple-choice question immediately below the grid, forcing the patient to read it individually.
Expert tip: If your digital form software supports conditional logic, set up a hidden routing rule based on question nine. If a patient selects anything other than
Not at allfor the self-harm item, trigger a custom confirmation screen providing immediate crisis hotline numbers.
For clinics digitizing old paperwork, manually typing out these matrices can introduce typos that invalidate the tool. Using a dedicated document conversion tool ensures the exact text from the validated paper version maps perfectly into the digital grid without manual data entry errors.
How often should providers administer follow-up screenings?
The true power of the PHQ-9 lies in serial administration over the lifespan of a patient's care. A single score tells you where the patient is today, but tracking scores over time tells you if your treatment plan is actually working. This approach, known as measurement-based care, relies on objective data to guide clinical adjustments rather than relying on a patient saying they "feel a bit better." Administering the tool at the right intervals ensures you catch non-responders early and adjust medications or therapy goals promptly.
| Frequency | Clinical context | Treatment tracking goals |
|---|---|---|
| Baseline | Initial intake | Establish the starting severity and document a numerical baseline before any intervention begins. |
| Every 2 to 4 weeks | New medication initiation | Monitor early physiological response, catch worsening symptoms, and justify dosage increases. |
| Every session | Acute psychotherapy | Track weekly micro-changes, measure subjective distress, and guide the immediate focus of the therapy hour. |
| Every 3 to 6 months | Maintenance phase | Ensure the patient remains in stable remission and detect early warning signs of a depressive relapse. |
Clinically, providers look for a significant drop in the total score to validate their approach. A reduction of 5 points or more is generally considered a clinically significant response to treatment, indicating the intervention is working. A total score dropping below 5 indicates the patient has reached remission.
If the score remains stagnant after four to six weeks of active treatment, the data gives you a clear, objective reason to pivot your strategy. You can use the historical grid responses to show the patient exactly which symptoms are stubbornly persisting. For example, if their mood has improved but their score remains high due to sleep disturbance and fatigue, you can target those specific physiological symptoms directly.
FAQ
Can the PHQ-9 be used to diagnose major depressive disorder?
No, the questionnaire is a screening and severity-tracking tool, not a standalone diagnostic instrument. A high score indicates a high probability of depression, but a formal diagnosis requires a comprehensive clinical interview. Providers must rule out bipolar disorder, normal bereavement, and underlying physical medical conditions before confirming Major Depressive Disorder in a patient's chart.
What is the difference between the PHQ-2 and the PHQ-9?
The PHQ-2 is an ultra-brief screener consisting of only the first two questions of the full questionnaire, measuring anhedonia and depressed mood. It is used in high-volume settings like emergency rooms or primary care to quickly filter out patients who do not need a full mental health assessment. If a patient scores a 3 or higher on the PHQ-2, the provider then administers the remaining seven questions to determine total severity.
Is the PHQ-9 free to use for clinical providers?
Yes, the tool is entirely free for clinical, educational, and research use. It was originally developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke through an educational grant from Pfizer Inc. No specific permission or licensing fee is required to reproduce, translate, display, or distribute the questionnaire in your practice.
How do you score question 9 on suicidal ideation?
Question nine is evaluated independently from the total numerical score and carries immediate clinical weight.
If a patient selects Several days, More than half the days, or Nearly every day for this item, it represents a positive screen for severe risk.
This positive response mandates an immediate, comprehensive safety assessment by a qualified clinician, regardless of how low the overall total score is.
Using the PHQ-9 consistently transforms vague subjective reports into trackable, actionable data. It takes the guesswork out of assessing symptom severity and provides a clear, objective language that both you and your patient can share. If you are migrating an older paper-based practice into a modern clinical workflow, a tool like Doc2Form can automatically convert your existing PDF intake packets into secure Google Forms. Start with a solid baseline, track the numbers diligently over time, and let the data guide your clinical decisions.